What We Do
Who We Are
Simulations
Presentations & Research
Contact Us
White Paper
Disclaimer
Industry Sector
Global Region
ETF's and Futures
Major Funds - Holding
Tutorial
Best Risk Adjusted
Worst Risk Adjusted
Best Expected
Worst Expected
Sector Ranking
Dividend
REIT's
Leverage Risk
Convertible Bonds
Investment Grade
High Yield
ADR
Small Caps
Rational Investing
About Us
arrow_drop_down
Coverage
arrow_drop_down
Returns
arrow_drop_down
Product
arrow_drop_down
Drugs - Generic
Total Market Capitalization of All Firms
$100,519 mm
Average Market Capitalization
$14,360 mm
Average Market to Model Ratio Weighted by Log of Market Cap
1.1
Standard Deviation of MM Ratio
0.6
Average Beta
1.2
Average EV To Revenue
3.2
Average EV To EBITDAM
14.6
Average Price To Free Cash Flow
12.8
Ticker
Company Name
Market To Model
Market Cap ($ mm)
EV to Revenue
Price To FCF
EV/EBITDAM
% Growth
Beta
As Of
RDY
Dr Reddy Laboratories Ltd
2.24
11,396
4.7
29.2
28.9
1
0.3
Sep 20
PRGO
Perrigo Co.
1.47
5,905
1.8
10.9
11.7
6
1.2
Sep 20
ANIP
ANI Pharmaceuticals Inc
1.35
383
2.7
12.7
14.5
4
1.8
Sep 19
AGN
Allergan PLC
1.00
58,871
4.9
15.8
17.0
3
1.2
Mar 20
TEVA
Teva Pharmaceutical Industries
0.67
13,077
2.4
4.8
10.1
5
1.5
Sep 20
PBH
Prestige Brands Holdings Inc.
0.61
1,966
3.8
11.2
11.9
2
0.8
Sep 20
MYL
Mylan N.V.
0.59
8,922
1.9
4.9
8.4
3
1.4
Sep 20
Standard Value
|
About us
|
Contact us
    Copyright © 2003-2021 Rational Investing LLC ® | All Rights Reserved